Misago® SXR08060LRecalls & reported problems
Terumo Corporation · MISAGO RX Self-expanding Peripheral Stent · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04987350722300), received between Mar 17, 2016 and Dec 24, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Fracture” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Fracture1
Patient problems
- No Consequences Or Impact To Patient1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 24, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ADDITIONAL INFORMATION WAS RECEIVED ON 13DEC2019. AT THE TIME OF SURGERY AND INITIAL POST OP THE PATIENT WAS WELL. THERE HAS BEEN NO FOLLOW UP SINCE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9517145 ↗InjuryMar 17, 2016Fracture; Fracture
THE USER FACILITY REPORTED THAT THE MISAGO DEVICE APPEARED TO BE FRACTURED. FOLLOW UP COMMUNICATION WITH THE USER FACILITY CONFIRMED THE FOLLOWING INFORMATION: THE PHYSICIAN PUT IN A MISAGO STENT ON (B)(6) 2016; THE SUPERIOR FEMORAL ARTERY WAS VERY CALCIFIED AND THE SFA WAS PRETTY LARGE; THE PATIENT WAS BROUGHT BACK ON (B)(6) 2016 TO PLACE A SUPERA STENT IN THE POPLITEAL ARTERY; THE PHYSICIAN NOTICED THAT THE MISAGO STENT APPEARED TO BE FRACTURED; THE PHYSICIAN REALIGNED THE MISAGO STENT WITH AN ICAST STENT AND A VIABAHN; THE FLOW DOWN THE LEG APPEARED TO BE GOOD; THE PROCEDURE WAS COMPLETED; AND THE PATIENT WAS REPORTED AS DOING GOOD.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 5507146 ↗
Other Stent, Superficial Femoral Artery devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page